HORIZON

📅 Upcoming

🕒 Recent(90d)

News

• Alnylam absorbs $10.8B blowback after cutting full-year guidance for TTR franchise
  Alnylam’s revenue cut “may create a near term credibility overhang and could “raise questions on peak sales potential, even if there’s tailwinds in the competitive landscape,” according to Stifel.
  biospace · 12h ago
• J&J nabs option to buy ‘in vivo’ CAR-T maker Sail for nearly $2.6B
  The deal with the buzzy Flagship Pioneering-backed startup makes J&J the latest large drugmaker to bet that the technology might be able to treat autoimmune conditions.
  biopharma_dive · 1d ago
• Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues
  Sanofi's new CEO Belén Garijo opened up for the first time about her strategy to reverse a trend of clinical setbacks, including dumping Regeneron-partnered IL-33 candidate itepekimab.
  fiercebiotech · 1d ago
• GSK cost-cutting plan includes global layoffs
  Follow along as BioSpace tracks job cuts and restructuring initiatives.
  biospace · 2d ago
• Biotechs bring big launches and pharma rivalries into Q2 earnings period
  With the second quarter earnings period underway, BioSpace examines five biotechs with meaningful catalysts that analysts and investors are watching.
  biospace · 2d ago
• An eye drug biotech banks $118M and stocks its executive suite
  Claris Bio has appointed veteran CEO Stephen Brady to lead advanced development of what it hopes to be the first drug therapy for a blinding condition called limbal stem cell deficiency.
  biopharma_dive · 3d ago
• Amgen sheds around 40 staffers amid continuing struggles
  Amgen has laid off around 40 employees as part of “organizational changes” meant to better align operations with the company’s strategic objectives, Fierce has learned.
  fiercebiotech · 7d ago
• US ‘eroding’ lead in rare diseases a matter of national security: Report
  A Congressional advisory panel recommends the U.S. government put supportive policies in place for rare disease drug development, such as a finalized platform designation from the FDA and the allow…
  biospace · 9d ago
• As Maui recovers from devastating fires, a study offers vision for new rural health model
  A study of the long-term health impact of the Lahaina wildfires is inspiring a new model for disaster recovery and support.
  stat · 9d ago
• Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independence
  After the trailblazing approval of Sanofi’s Tzield for stage 3 type 1 diabetes, several companies, including SAB Biotherapeutics and Eledon Pharmaceuticals, are vying for a spot in the landscape wi…
  biospace · 11d ago